MedPath

Postelmans Laurence

🇧🇪Belgium
Ownership
-
Employees
-
Market Cap
-
Website

Analysis of naïve Patients With Age-related Macular Degeneration of the Neovascular Type and Treated With Aflibercept (Eylea®) in "Treat-and-extend" at CHU Brugmann

Completed
Conditions
Age-related Macular Degeneration
First Posted Date
2021-05-18
Last Posted Date
2022-03-08
Lead Sponsor
Laurence Postelmans
Target Recruit Count
36
Registration Number
NCT04891835
Locations
🇧🇪

CHU Brugmann, Brussels, Belgium

Prevalence and Risk Factors of Epiretinal Membrane in Diabetic and Non-diabetic Patients

Completed
Conditions
Epiretinal Membrane
Interventions
Device: Slit lamp examination
Device: Undilated 7-field color fundus photography
Device: Color scan
Device: Spectral domain optical coherence tomography
First Posted Date
2017-12-05
Last Posted Date
2020-07-09
Lead Sponsor
Laurence Postelmans
Target Recruit Count
200
Registration Number
NCT03362580
Locations
🇧🇪

CHU Brugmann, Brussels, Belgium

© Copyright 2025. All Rights Reserved by MedPath